Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for ...
The Business & Financial Times on MSN9h
Stem cell therapy best bet at reducing rising NCD burden – expertBy Ebenezer Chike Adjei NJOKU Dr. Davies Kofie Adedze, a leading advocate for regenerative medicine, has stated that stem cell therapy could significantly reduce the country’s burden of ...
New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...
Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback